Philippines Pharmaceuticals and Healthcare Report Q1 2016

Date: December 23, 2015
Pages: 103
Price:
US$ 1,295.00
Publisher: BMI RESEARCH
Report type: Strategic Report
Delivery: Download
ID: P6B349D12C4EN
Leaflet:

Download PDF Leaflet

Includes 3 FREE quarterly updates

BMI View: Healthcare access in the Philippines has improved through the expansion of the country's universal health insurance scheme and the proposed 2016 government budget will aid further expansion.

The country's growing population, increasing disease burden (particularly cancer and cardiovascular diseases) and rising acceptance of affordable generic drugs, will drive growth in the pharmaceutical market. However, pharmaceutical firms seeking to capture the commercial opportunities from the large unmet medical need in the Philippines's oncology space will face challenges, as undiagnosed cancer cases remain high and many advanced treatments still require out of pocket payment.

Headline Expenditure Projections
  • Pharmaceuticals: PHP145.05bn (USD3.28bn) in 2014, rising to PHP150.44bn (USD3.27bn) in 2015; +3.7% in local currency terms and -0.3% in US dollar terms. Forecast revised downwards slightly from last quarter.
  • Healthcare: PHP562.90bn (USD12.74bn) in 2014, rising to PHP622.99bn (USD13.54bn) in 2015; +10.7% in local currency terms and +6.4% in US dollar terms. Revised downwards from last quarter.
BMI Industry View
    Table: Headline Pharmaceuticals & Healthcare Forecasts (Philippines 2013-2019)
SWOT
Industry Forecast
Pharmaceutical Market Forecast
    Table: Pharmaceutical Sales, Historical Data And Forecasts (Philippines 2011-2019)
Healthcare Market Forecast
    Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Philippines 2011-2019)
    Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Philippines 2011-2019)
    Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Philippines 2011-2019)
Prescription Drug Market Forecast
    Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Philippines 2011-2019)
Patented Drug Market Forecast
    Table: Patented Drug Market Indicators, Historical Data And Forecasts (Philippines 2011-2019)
Generic Drug Market Forecast
    Table: Generic Drug Market Indicators, Historical Data And Forecasts (Philippines 2011-2019)
OTC Drug Market Forecast
    Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Philippines 2011-2019)
Pharmaceutical Trade Forecast
    Table: Pharmaceutical Trade Data And Forecasts (Philippines 2013-2019)
    Table: Pharmaceutical Trade Data And Forecasts local currency (Philippines 2013-2019)
Industry Risk/Reward Index
Asia Pacific Risk/Reward Index
Philippines Risk/Reward Index
Rewards
Risks
Regulatory Review
    Table: History Of Food And Drugs Administration
Intellectual Property Regime
Pricing Regime
    Table: Medicines Subject To March 31 2010 Government Mediated Access Price
Reimbursement Regime
International Cooperation
Market Overview
Epidemiology
Healthcare Sector
    Table: Healthcare Resources (Philippines 2009-2014)
    Table: Healthcare Personnel (Philippines 2009-2014)
    Table: Healthcare Activity (Philippines 2009-2014)
Health Insurance
Healthcare Sector Financing
Medical Tourism
Biotechnology And Research
Traditional Medicines
Clinical Trials
Competitive Landscape
Pharmaceutical Industry
    Table: Multinational Market Activity
Domestic Pharmaceutical Industry
Pharmaceutical Distribution And Retail
    Table: Overview Of BnB, BNB and P100 Programme
    Table: Cost Of Generic Drugs In Philippines (PHP)
    Table: Number Of BnBs And BNBs In Selected Philippine Regions
Company Profile
GlaxoSmithKline Philippines
Novartis
Demographic Forecast
    Table: Population Headline Indicators (Philippines 1990-2025)
    Table: Key Population Ratios (Philippines 1990-2025)
    Table: Urban/Rural Population & Life Expectancy (Philippines 1990-2025)
    Table: Population By Age Group (Philippines 1990-2025)
    Table: Population By Age Group % (Philippines 1990-2025)
Glossary
Methodology
Pharmaceutical Expenditure Forecast Model
Healthcare Expenditure Forecast Model
Notes On Methodology
Risk/Reward Index Methodology
Index Overview
    Table: Pharmaceutical Risk/Reward Index Indicators
Indicator Weightings
Skip to top


Ask Your Question

Philippines Pharmaceuticals and Healthcare Report Q1 2016
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: